Guerbet SA (EPA:GBT)
15.24
+0.48 (3.25%)
At close: Nov 10, 2025
Guerbet Market Cap
Guerbet has a market cap or net worth of €185.99 million as of November 10, 2025. Its market cap has decreased by -53.54% in one year.
Market Cap
185.99M
Enterprise Value
532.97M
Revenue
820.92M
Ranking
n/a
PE Ratio
24.04
Stock Price
€15.24
Market Cap Chart
Since March 3, 1992, Guerbet's market cap has increased from 142.85M to 185.99M, an increase of 30.21%. That is a compound annual growth rate of 0.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2025 | 192.04M | -43.17% |
| Dec 31, 2024 | 337.92M | 37.29% |
| Dec 29, 2023 | 246.14M | 14.95% |
| Dec 30, 2022 | 214.13M | -54.42% |
| Dec 31, 2021 | 469.83M | 13.67% |
| Dec 31, 2020 | 413.32M | -20.32% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 144.20B |
| Sanofi | 103.96B |
| Sartorius Stedim Biotech | 18.53B |
| bioMérieux | 12.44B |
| Eurofins Scientific SE | 10.34B |
| Ipsen | 10.18B |
| ABIVAX Société Anonyme | 6.62B |
| Virbac | 2.83B |